The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 165.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 25.00 (15.152%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
ATY Live PriceLast checked at -
Athelney is an Investment Trust

To provide shareholders with prospects of long term capital growth by investing in companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Letter to Shareholders

18 Mar 2019 09:05

RNS Number : 1576T
Athelney Trust PLC
18 March 2019
 

Dear Fellow Shareholders

 

I am writing to you ahead of the Annual General Meeting on 3 April 2019 when we will all be voting on resolutions required in terms of the Companies Act and a few that I have proposed. The purpose of this letter is to explain my reasons for the additional agenda items and why I believe we should remove the current Board in its entirety, appoint Simon to the Board and definitely not authorise the issue of any shares by the current directors.

 

In essence my rationale for these recommendations is based on the following observations:

· There is zero alignment of interest between the current directors, Gresham House (who recommended their appointment) and the shareholders of Athelney. Gresham House clearly have their own agenda to pursue and none of the current directors' have taken the time to acquaint themselves with the other Athelney shareholders as Simon Moore had done during his brief stint as a director and Chairman. Furthermore, as far as I am aware, neither Gresham House nor any of the current directors own any shares in Athelney, a requirement in any small company to ensure alignment of interest.

· Athelney has always been an extremely well-run Investment Trust with a low-cost structure and a compliance regime suitable for a small company. It would appear that the current directors have increased the cost base with increased travel and consultant fees, using corporate governance as the reason which is modern parlance for a complete lack of experience in the running of the relevant business.

· In a recent Royal Commission into the Financial Services Industry, Justice Haynes found that the poor performance of financial institutions was due to a failure at Board level to ensure an appropriate culture, governance structure and remuneration system. While he confirmed that Boards of Companies are responsible to shareholders, they also have an obligation to all stakeholders such as employees, service providers and customers and more importantly, in the execution of their duties the Boards cannot and must not involve themselves in the day to day management of the Corporation. The current board, in spite of having no meaningful funds management experience, have on a number of occasions attempted to interfere in both stock selection and asset selection, both of which are not the responsibility of the board but of the investment manager, not only contractually but also as indicated by Justice Haynes as a requirement to ensure good corporate governance.

· Athelney has always had a culture best described as one of a personalised touch, provided not only by Robin Boyle but also by John Girdlestone and his team at GW & Co. The current sidelining by the Board of GW & Co with the clear intention of replacing them by a larger firm, implies that their many years of amazing service to Athelney actually means nothing. I find this disgraceful, destroying the firm culture and also contrary to the findings of Justice Haynes.

· Simon Moore has a long career in investment trusts and has a strong reputation in the sector. He will bring a deep understanding of Athelney Trust, fellow shareholders, other stakeholders and the technical details required of running an investment trust, all of which the current board lack.

· I have made an offer to Robin to work with Simon and I over the next two years to bring about an orderly transition and have received no response.

 

The annual report contains a detailed explanation of our approach to investing. In addition, I urge shareholders to google my name to see what I stand for and what I have accomplished. I hope you will consider what I have to say and vote as I suggest.

 

Yours faithfully,

 

Dr Manny Pohl B.Sc (Eng), MBA, DBA, FAICD, MSAFAA, F Fin

4 March 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAJPMPTMBABMRL
Date   Source Headline
7th May 20249:54 amRNSNet Asset Value(s)
4th Apr 20249:21 amRNSNet Asset Value(s)
22nd Mar 20248:15 amRNSAGM Statement
5th Mar 20242:04 pmRNSNet Asset Value(s)
13th Feb 202411:58 amRNSDividend Declaration
5th Feb 202410:17 amRNSNet Asset Value(s)
3rd Jan 202411:13 amRNSNet Asset Value(s)
5th Dec 20232:45 pmRNSNet Asset Value(s)
6th Nov 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:29 amRNSAuditor appointment
10th Oct 202310:54 amRNSChange of Adviser
4th Oct 20232:58 pmRNSNet Asset Value(s)
4th Sep 202311:17 amRNSNet Asset Value(s)
2nd Aug 20239:06 amRNSNet Asset Value(s)
25th Jul 202311:37 amRNSHalf-year Report
4th Jul 20238:50 amRNSNet Asset Value(s)
5th Jun 20237:28 amRNSNet Asset Value(s)
3rd May 202310:14 amRNSNet Asset Value(s)
4th Apr 202312:05 pmRNSNet Asset Value(s)
17th Mar 20231:15 pmRNSResult of AGM
2nd Mar 202312:39 pmRNSNet Asset Value(s)
13th Feb 20236:02 pmRNSAnnual Financial Report
2nd Feb 20237:00 amRNSNet Asset Value(s)
9th Jan 202310:11 amRNSNet Asset Value(s)
5th Dec 20227:51 amRNSNet Asset Value(s)
2nd Nov 20227:50 amRNSNet Asset Value(s)
4th Oct 20229:02 amRNSNet Asset Value(s)
5th Sep 20227:09 amRNSNet Asset Value(s)
2nd Aug 202211:57 amRNSNet Asset Value(s)
26th Jul 202212:44 pmRNSHalf-year Report
4th Jul 20229:13 amRNSNet Asset Value(s)
6th Jun 20229:36 amRNSNet Asset Value(s)
4th May 20227:56 amRNSNet Asset Value(s)
5th Apr 20223:10 pmRNSAGM Statement
4th Apr 20229:55 amRNSNet Asset Value(s)
2nd Mar 202211:33 amRNSNet Asset Value(s)
23rd Feb 20221:13 pmRNSAnnual Financial Report
2nd Feb 20229:05 amRNSNet Asset Value(s)
12th Jan 20225:03 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
5th Jan 20228:14 amRNSNet Asset Value(s)
3rd Dec 202112:00 pmRNSNet Asset Value(s)
2nd Nov 20218:12 amRNSNet Asset Value(s)
4th Oct 202111:40 amRNSNet Asset Value(s)
2nd Sep 202111:44 amRNSNet Asset Value(s)
3rd Aug 20211:18 pmRNSNet Asset Value(s)
27th Jul 202111:20 amRNSHalf-year Report
2nd Jul 20218:32 amRNSNet Asset Value(s)
3rd Jun 20218:19 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.